12.8 C
London
Friday, October 18, 2024
Subscribe
HomeTagsEisai

Tag: Eisai

spot_imgspot_img
Business

Japan – Eisai: DIAN-TU Selects Lecanemab as Background Anti-Amyloid Therapy in Clinical Trial Evaluating Investigational Therapy Targeting Tau for Dominantly Inherited Alzheimer’s Disease

Eisai Co., Ltd. announced today that the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St....
Business

Japan – Eisai Presents New Data on the Relationship Between Clinical, Biomarker and Safety Outcomes from the Lecanemab Phase 2B Study

Eisai Co., Ltd. announced today the presentation of data from the company's extensive Alzheimer's disease (AD) pipeline, including six oral presentations that will...
Business

Japan – Eisai Initiates Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab (BAN2401) for Early Alzheimer’s Disease Under the Accelerated...

Eisai Co., Ltd. and Biogen Inc. today announced that Eisai has initiated a rolling submission to the U.S. Food and Drug Administration (FDA)...
Business

Japan – Eisai to Join The Global Environmental Initiative “RE100”

Eisai Co., Ltd. announced today that it has joined "RE100", the global environmental initiative that aims to shift the electricity used in business...
Business

Eisai to Present Abstracts on Oncology Products and Pipeline at ESMO Virtual Congress 2021

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that presentations on a series of abstracts highlighting updates on its oncology products...
Business

Japan – Eisai and FUJI YAKUHIN Conclude License Agreement Concerning the Development and Distribution of Dotinurad in Five ASEAN Countries

Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD. announced today that they have concluded a license agreement concerning dotinurad (generic name), a treatment...
Business

Eisai and Biogen Present Preliminary Assessment of the Clinical Effects of Lecanemab (BAN2401)

Eisai Co., Ltd. and Biogen Inc. today announced results of a longitudinal preliminary assessment of the clinical effects of lecanemab (development code: BAN2401) --...
1...111213...15Page 12 of 15

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img

Company

Each template in our ever growing studio library can be added and moved around within any page effortlessly with one click.

Latest

Leaders Corporate Announces Strategic Partnership with Shomi to Implement Odoo ERP

Business 0
By integrating Odoo ERP, Leaders Corporate will consolidate essential...

Orgmytrip Launches Innovative Flight Booking Service to Enhance Travel Experience

Business 0
Travelers can now search, compare, and book flights from...

Skool O’ Foolz Kids Rap Group Drops Rapperz Delight on Spotify, Apple Music, Pandora, Amazon, Tidal, Napster, and Other Streaming Services

Business 0
Skool O' Foolz is a San Francisco based Gum...

Popular

Leaders Corporate Announces Strategic Partnership with Shomi to Implement Odoo ERP

Business 0
By integrating Odoo ERP, Leaders Corporate will consolidate essential...

Orgmytrip Launches Innovative Flight Booking Service to Enhance Travel Experience

Business 0
Travelers can now search, compare, and book flights from...

Skool O’ Foolz Kids Rap Group Drops Rapperz Delight on Spotify, Apple Music, Pandora, Amazon, Tidal, Napster, and Other Streaming Services

Business 0
Skool O' Foolz is a San Francisco based Gum...

Sitemap

© 2004-2024 Webnewswire, All Rights Reserved